Cargando…

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

BACKGROUND: Parkinson’s disease (PD) is a progressive neurological disorder where loss of dopamine neurons in the substantia nigra and dopamine depletion in the striatum cause characteristic motor symptoms. Currently, no treatment is able to halt the progression of PD. Glial cell line-derived neurot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renko, Juho-Matti, Mahato, Arun Kumar, Visnapuu, Tanel, Valkonen, Konsta, Karelson, Mati, Voutilainen, Merja H., Saarma, Mart, Tuominen, Raimo K., Sidorova, Yulia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461720/ https://www.ncbi.nlm.nih.gov/pubmed/34024778 http://dx.doi.org/10.3233/JPD-202400

Ejemplares similares

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Glial Cell Line–Derived Neurotrophic Factor Receptor Rearranged During Transfection Agonist Supports Dopamine Neurons In Vitro and Enhances Dopamine Release In Vivo
por: Mahato, Arun Kumar, et al.
Publicado: (2019)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats
por: Renko, Juho-Matti, et al.
Publicado: (2018)

Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action
por: Voutilainen, Merja H., et al.
Publicado: (2017)

Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
por: Ivanova, Larisa, et al.
Publicado: (2018)

PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential
por: Yadav, Leena, et al.
Publicado: (2020)

Molecular Dynamics Simulations of the Interactions between Glial Cell Line-Derived Neurotrophic Factor Family Receptor GFRα1 and Small-Molecule Ligands
por: Ivanova, Larisa, et al.
Publicado: (2018)

Novel RET agonist for the treatment of experimental neuropathies
por: Viisanen, Hanna, et al.
Publicado: (2020)

A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat
por: Sidorova, Yulia A., et al.
Publicado: (2017)

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer
por: Mahato, Arun Kumar, et al.
Publicado: (2020)

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
por: Albert, Katrina, et al.
Publicado: (2019)

Zebrafish GDNF and its co-receptor GFRα1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro
por: Saarenpää, Tuulia, et al.
Publicado: (2017)

Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons
por: Selberg, Simona, et al.
Publicado: (2021)

Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson’s disease
por: Mahato, Arun Kumar, et al.
Publicado: (2020)

Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration
por: Sidorova, Yulia A., et al.
Publicado: (2020)

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism
por: Lindholm, Päivi, et al.
Publicado: (2021)

Implementation of deep neural networks to count dopamine neurons in substantia nigra
por: Penttinen, Anna‐Maija, et al.
Publicado: (2018)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
por: Bäck, Susanne, et al.
Publicado: (2013)

Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration
por: Haider, Malik Salman, et al.
Publicado: (2022)

Methamphetamine-Induced Dopamine-Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats
por: Cadet, Jean Lud, et al.
Publicado: (2010)

Netrin‐1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson’s disease features
por: Jasmin, Mélissa, et al.
Publicado: (2020)

RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications
por: Mutso, Margit, et al.
Publicado: (2015)

A deep convolutional neural network approach for astrocyte detection
por: Suleymanova, Ilida, et al.
Publicado: (2018)

Simultaneous Measurement of Striatal Dopamine and Hydrogen Peroxide Transients Associated with L-DOPA Induced Rotation in Hemiparkinsonian Rats
por: Wilson, Leslie R., et al.
Publicado: (2021)

Alterations of Sleep and Sleep Oscillations in the Hemiparkinsonian Rat
por: Ciric, Jelena, et al.
Publicado: (2019)

Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns
por: Kordys, Elena, et al.
Publicado: (2017)

Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP(+) in dissociated cultures from rat mesencephalon
por: Jaumotte, Juliann D., et al.
Publicado: (2021)

Gfra1 Underexpression Causes Hirschsprung’s Disease and Associated Enterocolitis in Mice
por: Porokuokka, L. Lauriina, et al.
Publicado: (2018)

The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy
por: Ivanova, Larisa, et al.
Publicado: (2022)

Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats
por: Hsieh, Tsung-Hsun, et al.
Publicado: (2021)

Validations of apomorphine-induced BOLD activation correlations in hemiparkinsonian rhesus macaques
por: Quintero, J.E., et al.
Publicado: (2019)

Exercise Improves Movement by Regulating the Plasticity of Cortical Function in Hemiparkinsonian Rats
por: Shi, Kaixuan, et al.
Publicado: (2021)

Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate
por: Rangasamy, Suresh B., et al.
Publicado: (2022)

Dopamine System, NMDA Receptor and EGF Family Expressions in Brain Structures of Bl6 and 129Sv Strains Displaying Different Behavioral Adaptation
por: Varul, Jane, et al.
Publicado: (2021)

Identification of Natural Compounds against Neurodegenerative Diseases Using In Silico Techniques
por: Ivanova, Larisa, et al.
Publicado: (2018)

Multitarget Approach to Drug Candidates against Alzheimer’s Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets
por: Ivanova, Larisa, et al.
Publicado: (2020)

Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
por: Albert, Katrina, et al.
Publicado: (2021)

Roles of Motor Cortex Neuron Classes in Reach-Related Modulation for Hemiparkinsonian Rats
por: Li, Min, et al.
Publicado: (2021)

MANF Ablation Causes Prolonged Activation of the UPR without Neurodegeneration in the Mouse Midbrain Dopamine System
por: Pakarinen, Emmi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hmh4m8at5qmasq4q9c1263l4ja